Improving FDA postmarket adverse event reporting for medical devices

被引：2
|
作者：
Wunnava, Susmitha [1 ,2 ]
Miller, Timothy A. [2 ,3 ]
Bourgeois, Florence T. [2 ,3 ]
机构：
[1] Harvard Med Sch, Harvard Mit Ctr Regulatory Sci, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA
来源：
BMJ EVIDENCE-BASED MEDICINE | 2023年 / 28卷 / 02期
关键词：
diagnosis; health care quality; access; and evaluation; policy; public health; therapeutics; DATABASE; UTILITY;
D O I：
10.1136/bmjebm-2021-111870
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [1] FDA amends postmarket program for medical devices
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (01) : 24N - 24N
  • [2] GENDER DISPARITIES IN ADVERSE EVENT REPORTING FOR MEDICAL DEVICES
    Pierce, Hudson
    Ahsan, Muhammad
    Goel, Shokhi
    Asfaw, Tirsit
    Anger, Jennifer
    Chughtai, Bilal
    JOURNAL OF UROLOGY, 2020, 203 : E1256 - E1257
  • [3] Implementation of adverse event reporting for medical devices, India
    Shukla, Shatrunajay
    Gupta, Madhur
    Pandit, Sabitri
    Thomson, Milu
    Shivhare, Abhimanyu
    Kalaiselvan, Vivekanandan
    Singh, Gyanendra Nath
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2020, 98 (03) : 206 - 211
  • [4] IN VIDEO, FDA URGES ADVERSE EVENT REPORTING
    Cima, Greg
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2021, 259 (03): : 223 - 223
  • [5] Security and Privacy Qualities of Medical Devices: An Analysis of FDA Postmarket Surveillance
    Kramer, Daniel B.
    Baker, Matthew
    Ransford, Benjamin
    Molina-Markham, Andres
    Stewart, Quinn
    Fu, Kevin
    Reynolds, Matthew R.
    PLOS ONE, 2012, 7 (07):
  • [6] Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
    He, Chang-Zhu
    Qiu, Qin
    Lu, Song-Jie
    Xue, Fu-Li
    Liu, Jun-Qiao
    He, Yu
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [7] Missing data in FDA adverse event reporting systems
    Smith, Sheila Weiss
    Gogolak, Victor V.
    Deshpande, Gaurav
    Chung, Stephanie
    Mehta, Shekhar H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S72 - S72
  • [8] An evaluation of the FDA adverse event reporting system and the potential for reporting bias
    Monnot, Andrew D.
    Fung, Ernest S.
    Compoginis, Goli S.
    Towle, Kevin M.
    JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (06) : 1849 - 1854
  • [9] Vedolizumab Adverse Events: Analysis of the FDA Adverse Event Reporting System
    Jow, Steven
    Hutfless, Susan
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S35 - S36
  • [10] Postmarket adverse event reporting rates: How well do they approximate incidence estimates
    Hammond, Isaac W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S127 - S127
12345